BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Mallinckrodt Inc. 

675 McDonnell Boulevard

Hazelwood  Missouri  63042  U.S.A.
Phone: 314-654-2000 Fax: 314-654-5381


SEARCH JOBS


Industry
Medical Device


Collaborations

Advanced Magnetics, Inc.  GastroMARK in North America





 Company News
Mallinckrodt Inc. Eliminates 100 Jobs, 35 in St. Louis 5/21/2013 8:23:03 AM    More...
Covidien (COV) and Mallinckrodt Inc. to Present at Bank of America (BAC) Merrill Lynch Conference 5/8/2013 7:59:09 AM    More...
Covidien plc (COV) Plans Mallinckrodt Inc. Spinoff for June 28 5/6/2013 7:31:47 AM    More...
Mallinckrodt Inc. to Sell $900 Million in Notes 4/8/2013 9:42:35 AM    More...
Mallinckrodt Inc. Launches Additional Dosage Strengths of Generic CONCERTA® in U.S. 3/25/2013 9:28:13 AM    More...
Mallinckrodt Inc. Announces Approval of New Gablofen® Prefilled Syringe 1/22/2013 10:00:30 AM    More...
Mallinckrodt Inc. Launches Generic Version of CONCERTA® in U.S. 1/2/2013 9:19:51 AM    More...
Mallinckrodt Inc. Completes Acquisition of CNS Therapeutics, Inc. 10/2/2012 10:14:21 AM    More...
Mallinckrodt Inc. Joins The Partnership at Drugfree.org to Launch The Medicine Abuse Project 9/25/2012 10:08:41 AM    More...
Covidien plc (COV)'s Mallinckrodt Inc. Announces Definitive Agreement to Acquire CNS Therapeutics, Inc. for $100 Million 9/24/2012 7:05:12 AM    More...
1234